ABSTRACT
Objectives Injudicious use of antimicrobial agents contributes to antimicrobial resistance. Antimicrobial Stewardship (AMS) interventions use strategies derived from evidence-based practices to ensure careful use of antibiotics. AMS is less common in paediatrics as compared to adult practice. As AMS success depends on organizational factors and individual behaviours, this study synthesizes the existing qualitative evidence exploring key barriers, facilitators, and acceptability of AMS.
Design A systematic search of primary qualitative studies was conducted in electronic databases.
Data sources MEDLINE, PsychINFO via OVID, CINAHL electronic database and handsearching of grey literature sources was done.
Eligibility criteria Qualitative studies exploring parents” and/or clinicians” (doctors and nurses) views, attitudes, beliefs, and knowledge on antimicrobial stewardship programmes in paediatric and neonatal hospitals.
Data extraction and synthesis Quality appraisal was done using the Critical Appraisal Skills Programme (CASP) tool for qualitative studies. The extracted data was then synthesised by drawing on meta-ethnography.
Results A total of 6 studies met the inclusion criteria. 5 studies reported the views and experiences of doctors and nurses, and 1 study reported those of parents. The perceived value of AMS differed in neonatal and paediatric contexts. Structural barriers like resource allocation and hospital organization were a barrier to implementation and acceptability. Nurses reported a lack of formal education about AMS as a barrier.
Conclusion/Implications The factors affecting AMS in paediatric secondary care vary with the stakeholders in question. This review identifies some of the factors that can be used to formulate service-level AMS interventions and programmes.
Strengths and limitations of the study
This is the first evidence synthesis of the qualitative literature exploring the beliefs and experiences of parents and clinicians regarding paediatric AMS.
The facilitators and barriers were identified from themes representative of all the included studies, increasing their validity.
While included studies were conducted across six countries, all were within the developed world which could limit the generalisability of the findings.
A limited number of studies was included due to limited number of primary studies conducted in this area.
Original protocol from PROSPERO Registration number: CRD42022346842
Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022346842 The process for data synthesis was changed from thematic analysis to meta-ethnography to accommodate the variety of ways in which the results were reported in the included studies.
Competing Interest Statement
Christie Cabral acknowledges support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other competing interests.
Clinical Protocols
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022346842
Funding Statement
Christie Cabral acknowledges support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used is reported in the results section of the included studies and is anonymised and publicly available. The studies have been cited in the manuscript.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
stefania.vergnano{at}uhbw.nhs.uk
christie.cabral{at}bristol.ac.uk
The Submitting Author accepts and understands that any supply made under these terms is made by BMJ to the Submitting Author unless you are acting as an employee on behalf of your employer or a postgraduate student of an affiliated institution which is paying any applicable article publishing charge (“APC”) for Open Access articles. Where the Submitting Author wishes to make the Work available on an Open Access basis (and intends to pay the relevant APC), the terms of reuse of such Open Access shall be governed by a Creative Commons licence – details of these licences and which licence will apply to this Work are set out in our licence referred to above.
The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in BMJ editions and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence.”
Competing interest statement: All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare:
Funding: Christie Cabral acknowledges support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.” Please note: The corresponding author must collect Unified Competing Interest forms from all authors and summarise their declarations as above within the manuscript.
Transparency declaration: The lead author, Nirzer Mate, affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned and registered, have been explained.
Details of ethical approval: As this study is a synthesis of results of qualitative studies, no ethical approval was needed. There was no patient or public involvement in the study.
Details of funding: Christie Cabral acknowledges support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funding support was received by the authors.
There was no patient and public involvement in the design, or conduct, or reporting, or dissemination plans of our research.
Data Availability
All data produced in the present work are contained in the manuscript.